Learn more

VITA INVEST SA

Overview
  • Total Patents
    184
About

VITA INVEST SA has a total of 184 patent applications. Its first patent ever was published in 1992. It filed its patents most often in Spain, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and environmental technology are CEDONA PHARM BV, CONTINENTAL PHARMA and INST FOR PHARM DISCOVERY INC.

Patent filings per year

Chart showing VITA INVEST SAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Del Castillo Nieto Juan Carlos 38
#2 Caldero Ges Jose Maria 32
#3 Bosch Rovira Anna 28
#4 Marquillas Olondriz Francisco 27
#5 De Ramon Amat Elisabet 26
#6 Huguet Clotet Joan 25
#7 Dalmases Barjoan Pere 24
#8 Mourelle Mancini Marisabel 24
#9 Nieto Juan Carlos Del Castillo 19
#10 Huguet Clotet Juan 19

Latest patents

Publication Filing date Title
ES2160090A1 Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration
ES2160534A1 New esters derived from (rr, ss) -2-hydroxibenzoate 3- (2-dimethylminome-1-hydroxiciclohexil) phenyl.
ES2156574A1 New derivatives of tiazolidindiona as antidiabetic agents
ES2161167A1 Enzymatic hydrolysis for paroxetine synthesis intermediates production consists of enantio selective hydrolysis of a racemic ester based mixture
ES2141688A1 NEW ESTERS DERIVED FROM SUBSTITUTED FENIL-CICLOHEXIL COMPOUNDS.
ES2142771A1 New derivatives of 6- (4-phenyl-butoxi) hexylamine and procedure for obtaining salmeterol.
ES2154551A1 New derivatives of tetrazol as antidiabetic agents.
CZ479499A3 Benzothiophene derivatives, use and preparations
ES2145702A1 Enzymatic procedure for obtaining (r) -2-hydroxi-4-phanylbutanoate of enantiomerically pure style using biocatalizers of immobilized lipasses.
ES2147121A1 New biocatalizers of immobilized lipasses.
ES2155740A1 Intrauretral device for the treatment of erectile dysfunction.
ES2137131A1 Derivative of piperidinone procedure for obtaining and procedure for its use.
ES2141671A1 Active pyrimidinic compound on the central nervous system, procedure for the preparation and pharmaceutical compositions containing it.
ES2138908A1 Polymorphes of 3- (2- (4- (6-fluorobenzo (d) isoxazol-3-il) 3.6. dihidro-2h-piridin-1-il) -etil) -2-methyl-6.7, 8,9-tetrahidropirido (1,2-a) pirimidin-4-ona and procedures for its obtaining.
ES2128266A1 Thiophene and benzotiofen derivative compounds and relevant use and composition.
ES2125198A1 Fixed-dose association of an angiotensin converting enzyme inhibitor and an antagonist of the calcium channels, procedure for its preparation and use for the treatment of cardiovascular diseases.
ES2134123A1 Improvements in containers for pharmaceutical and similar products.
ES2121685A1 Procedure for the obtaining of (+) - trans-4 (4-fluoro-fenil) -3-hidroximetil-1-methylpiperidine.
ES2121684A1 Procedure for the obtaining of (+) - cis / (+) - trans-4- (4-fluorofenil) -1-methylpiperidine-3-ethyl carboxylate.
ES2121682A1 4- (4-fluorophenyl) -2-piperdinone-5-ethyl ethyl and procedure for obtaining it.